At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
SITC SITE Centers Corp.
Trading 04-01 10:15:56 EDT
5.31
-0.09
-1.67%
High5.33Low5.30Vol50.55K
Open5.33D1 Closing5.40Amplitude0.52%
Mkt Cap278.58MTradable Cap277.44MTotal Shares52.46M
T/O268.66KT/O Rate0.10%Tradable Shares52.25M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

IMUNON Reports 2025 Financial Results and Provides Business Update Highlighting Significant Progress with Pivotal Phase 3 Study
GlobeNewswire  ·  03-31 20:00
IMUNON Reports 2025 Financial Results and Provides Business Update Highlighting Significant Progress with Pivotal Phase 3 Study
HOOKIPA Pharma Announces Completion of Sale of Oncology Assets to NeoTrail Therapeutics
GlobeNewswire  ·  03-26
HOOKIPA Pharma Announces Completion of Sale of Oncology Assets to NeoTrail Therapeutics
Press Release: Transgene Continues Progress to Reshape Early-Stage Cancer Treatment through Individualized Neoantigen Therapeutic Vaccines (INTV) Backed by Financial Visibility Until Early 2028
Dow Jones  ·  03-25
Press Release: Transgene Continues Progress to Reshape Early-Stage Cancer Treatment through Individualized Neoantigen Therapeutic Vaccines (INTV) Backed by Financial Visibility Until Early 2028
Site Centers Corp. Announces Annual Shareholder Meeting
Reuters  ·  03-14
Site Centers Corp. Announces Annual Shareholder Meeting
Akari Therapeutics Releases CEO Corner Highlighting Strategic Progress and Path to Clinical Development Under CEO Abizer Gaslightwala
GlobeNewswire  ·  03-13
Akari Therapeutics Releases CEO Corner Highlighting Strategic Progress and Path to Clinical Development Under CEO Abizer Gaslightwala
Molecular Partners Reports Highlights and Financial Results for Full Year 2025
GlobeNewswire  ·  03-13
Molecular Partners Reports Highlights and Financial Results for Full Year 2025
Corbus Pharmaceuticals Reports Q4 and 2025 Financial Results and Provides a Corporate Update
GlobeNewswire  ·  03-09
Corbus Pharmaceuticals Reports Q4 and 2025 Financial Results and Provides a Corporate Update
SITE Centers Reports Sale of 3030 North Broadway
MT Newswires Live  ·  03-04
SITE Centers Reports Sale of 3030 North Broadway
BRIEF-Site Centers Announces Sale Of 3030 North Broadway
Reuters  ·  03-04
BRIEF-Site Centers Announces Sale Of 3030 North Broadway
SITE Centers sells 3030 North Broadway for $50.1 million
Reuters  ·  03-04
SITE Centers sells 3030 North Broadway for $50.1 million
Site Centers Announces Sale of 3030 North Broadway
THOMSON REUTERS  ·  03-04
Site Centers Announces Sale of 3030 North Broadway
Site Centers Corp : Piper Sandler Cuts to Neutral From Overweight; Cuts Target Price to $6.5 From $8
THOMSON REUTERS  ·  03-02
Site Centers Corp : Piper Sandler Cuts to Neutral From Overweight; Cuts Target Price to $6.5 From $8
Site Centers sells FlatAcres MarketCenter for $24.4M
TIPRANKS  ·  02-28
Site Centers sells FlatAcres MarketCenter for $24.4M
SITE Centers sells FlatAcres MarketCenter for $24.4 million
Reuters  ·  02-28
SITE Centers sells FlatAcres MarketCenter for $24.4 million
Site Centers Announces Sale of Flatacres Marketcenter
THOMSON REUTERS  ·  02-28
Site Centers Announces Sale of Flatacres Marketcenter
Site Centers downgraded to Neutral from Overweight at Piper Sandler
TIPRANKS  ·  02-28
Site Centers downgraded to Neutral from Overweight at Piper Sandler
Piper downgrades Site Centers with stock value matching terminal value
TIPRANKS  ·  02-28
Piper downgrades Site Centers with stock value matching terminal value
ALX Oncology Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
GlobeNewswire  ·  02-27
ALX Oncology Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
SITE Centers posts Q4 net income on gains from property sales
Reuters  ·  02-27
SITE Centers posts Q4 net income on gains from property sales
BRIEF-SITE Centers Q4 Net Income USD 134.4 Million
Reuters  ·  02-27
BRIEF-SITE Centers Q4 Net Income USD 134.4 Million

Introduction

Company Name.
SITE Centers Corp.
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
SITE Centers is an owner and manager of open-air shopping centers located in suburban, high household income communities. The Company is a self-administered and self-managed REIT operating as a fully integrated real estate company, and is publicly traded on the New York Stock Exchange under the ticker symbol SITC.
Issue price:
--